Both insulin and IGF-1 are known to play a significant role in the regulation of myelin synthesis [35,36], and treatment with IGF-1 has been shown to protect oligodendrocytes in animal models of excitotoxicity and cerebral hypoxia-ischemia [37,38]. Here, IGF1 is linked to hypoxia.